General Topics

General Topics is a research-driven pharmaceutical and biotechnology company specialized in dermatology and aesthetic medicine. Founded in 1992 by Dr. Gianfranco de Paoli Ambrosi, the company operates through three core business units: Synchroline, which provides scientifically proven skin solutions for conditions like acne and rosacea; Tebitech, which focuses on advanced technologies and biotechnologies for professional aesthetic procedures; and Fillast, a line of technological luxury anti-aging cosmetics. With a portfolio of over 150 products and more than 90 international patents, General Topics is recognized for its innovative delivery systems, such as the Systemic Ternary technology used in its Enerpeel line of chemo-exfoliation medical devices. The company manages the entire product lifecycle from initial conceptualization and experimental research to international commercialization. Headquartered in Italy, General Topics maintains a global presence, supplying dermatologists and aesthetic professionals with high-performance topical treatments and medical devices designed to improve skin health and biomechanical properties.